Literature DB >> 2889094

Quinolone/ureidopenicillin cross-resistance.

L J Piddock, W J Wijnands, R Wise.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889094     DOI: 10.1016/s0140-6736(87)91387-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  22 in total

1.  Two efflux systems expressed simultaneously in multidrug-resistant Pseudomonas aeruginosa.

Authors:  L Pumbwe; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

2.  A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa.

Authors:  L J Piddock; M C Hall; F Bellido; M Bains; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

3.  Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy.

Authors:  J M Diver; T Schollaardt; H R Rabin; C Thorson; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

4.  Conservation of the multidrug resistance efflux gene oprM in Pseudomonas aeruginosa.

Authors:  N Bianco; S Neshat; K Poole
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

5.  Role of protein F in maintaining structural integrity of the Pseudomonas aeruginosa outer membrane.

Authors:  N Gotoh; H Wakebe; E Yoshihara; T Nakae; T Nishino
Journal:  J Bacteriol       Date:  1989-02       Impact factor: 3.490

Review 6.  Modulation of the host flora.

Authors:  R van Furth; H F Guiot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

Review 7.  Outer membrane barrier as a mechanism of antimicrobial resistance.

Authors:  H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

8.  Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin.

Authors:  J Bedard; S Chamberland; S Wong; T Schollaardt; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 9.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

10.  Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.

Authors:  K Poole; K Krebes; C McNally; S Neshat
Journal:  J Bacteriol       Date:  1993-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.